Fig. 5From: Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cellsEffects of ATO on xenograft tumor model a. Gross tumor extracted from nude mouse after 6 weeks of intraperitoneal administration of ATO with or without pervanadate. b. Difference in mean tumor volume among three groups. Data are presented as mean ± standard deviation. *P < 0.05, compared with control (n = 5). c. Changes of mean body weight. Data are presented as mean ± standard deviation. d. Immunohistochemistry of xenograft tumor. The SHP-1 protein expressions were stained dark brownBack to article page